Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600129244) titled 'Pathway construction and effectiveness evaluation of AI-enhanced influenza vaccination advocacy by primary healthcare providers for chronic obstructive pulmonary disease patients' on Aug. 1.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Peking University First Hospital
Condition:
Chronic obstructive pulmonary disease
Intervention:
Comparison:Usual care
Intervention:intelligent intervention
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-08-01
Target Sample Size: Comparison:247;Intervention:247;Observation group:990;
Countries of Recruitment:
C...